ERNZ:NSD-TrueShares Active Yield ETF (USD)

ETF | Others |

Last Closing

USD 23.551

Change

-0.30 (-1.25)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
IBIT iShares Bitcoin Trust

+0.49 (+1.00%)

USD 59.02B
QQQM Invesco NASDAQ 100 ETF

-0.73 (-0.36%)

USD 42.88B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.22 (-0.40%)

USD 22.89B
ACWI iShares MSCI ACWI ETF

-0.87 (-0.73%)

USD 19.98B
CGABL The Carlyle Group Inc. 4.625% ..

-0.10 (-0.55%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

+1.33 (+3.13%)

USD 4.90B
TBIL Rbb Fund Inc - Us Treasury 3 M..

+0.01 (+0.02%)

USD 4.81B
TSLL Direxion Shares ETF Trust - Di..

-1.14 (-9.00%)

USD 4.32B
ETHA iShares Ethereum Trust ETF

+0.11 (+0.68%)

USD 3.75B
USCL iShares Climate Conscious & Tr..

-0.86 (-1.21%)

USD 2.33B

ETFs Containing ERNZ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.83% 33% F 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.83% 33% F 52% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike